Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LNG Energy Announces Signing of Hydrocarbon Productive Participation Contracts (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Ampio Pharmaceuticals Inc AMPE

Healthcare
Ampio Pharmaceuticals, Inc. is a drug discovery and development company. The Company is focused on combining scientific, clinical, and manufacturing capabilities to develop therapies aimed at treating conditions for which limited treatment options exist.

Recent & Breaking News (OTCPK:AMPE)

Luoxis to Present at Biotech Showcase 2015

PR Newswire January 6, 2015

Ampio Pharmaceuticals to present at the Oppenheimer Annual Healthcare Conference on December 11th, 2014

PR Newswire December 4, 2014

Ampio Announces Results of the Open Label Portion of the Multiple Intra-articular Injections (STRUT) Study of Ampion(TM) in Patients with Osteoarthritis of the Knee at Week Twenty of the Trial

PR Newswire December 1, 2014

Luoxis Announces Presentation of Multiple Studies Validating RedoxSYS as a Rapid and Non-invasive Means of Assessing Oxidative Stress

PR Newswire November 24, 2014

Ampio updates status of clinical trials and manufacturing facility

PR Newswire November 12, 2014

Luoxis to Highlight RedoxSYS at Two Upcoming Scientific Conferences

PR Newswire October 20, 2014

Ampio Announces Results of the Open Label Portion of the Multiple Intra-articular Injections (MI) Study of Ampion(TM) in Patients with Osteoarthritis of the Knee at Week Twelve of the Trial

PR Newswire October 16, 2014

Ampio Pharmaceuticals Announces Webcast for Annual Shareholder Meeting

PR Newswire September 15, 2014

Ampio Pharmaceuticals Inc. (AMPE) Jumps 6.82% on September 11

Equities.com September 11, 2014

Ampio Pharmaceuticals Inc. (AMPE) Drops 7.08% on September 4

Equities.com September 4, 2014

Ampio Pharmaceuticals Inc. (AMPE) Drops 5.78% on September 3

Equities.com September 3, 2014

Update on the Phase III multicenter, double-blind STEP study of Ampion(TM) for Osteoarthritis of the Knee

PR Newswire September 2, 2014

Letter to the Ampio Shareholders in Regard to the STEP Study and Ampio's plans for the Ampion(TM) BLA

PR Newswire August 25, 2014

Ampio Pharmaceuticals Inc. (AMPE) Drops 14.49% on August 22

Equities.com August 22, 2014

Ampio Pharmaceuticals Inc. (AMPE) Drops 24.13% on August 21

Equities.com August 21, 2014

Ampio reports that due to temperature deviations below product specifications during shipments to the Ampion(TM) STEP Study clinical sites, release of data will be delayed

PR Newswire August 21, 2014

Analysis Of Available Data From Optimeyes Study (Blinded And Open Label) Of Optina(TM) For The Treatment Of Diabetic Macular Edema (DME) Indicates Potential For Significant Clinical Benefit

PR Newswire August 20, 2014

Leading Health Care Stock for Small-Cap Stars is Ampio Pharmaceuticals Inc. (AMPE) for August 19

Equities.com August 19, 2014

Luoxis Announces Presentation of Positive Clinical Findings from Five-Year Clinical Study of Traumatic Brain Injury and Oxidation-Reduction Potential at 2014 American Academy of Surgical Trauma Meeting

PR Newswire August 19, 2014

Leading Small-Cap Stars Health Care Stock for August 19 Morning Session is Horizon Pharma Inc. (HZNP)

Equities.com August 19, 2014